logo
The Freedom Center: Providing Integrated Treatment for Bipolar Disorder and Substance Abuse in Maryland

The Freedom Center: Providing Integrated Treatment for Bipolar Disorder and Substance Abuse in Maryland

BUCKEYSTOWN, MD, UNITED STATES, June 19, 2025 / EINPresswire.com / -- The Freedom Center Maryland Drug & Alcohol Rehab, a trusted leader in addiction and mental health treatment in Maryland, continues its commitment to offering integrated care for individuals suffering from co-occurring bipolar disorder and substance use disorders (SUDs). Located in Buckeystown, Maryland, The Freedom Center provides a safe, therapeutic environment where individuals can receive dual diagnosis treatment that addresses both mental health and addiction challenges simultaneously.
With a dedicated team of psychiatrists, licensed clinicians, and addiction professionals, The Freedom Center ensures that each client receives compassionate and comprehensive care tailored to their unique needs, guiding them toward long-term recovery and emotional wellness.
Comprehensive Dual Diagnosis Treatment Services
The Freedom Center's dual diagnosis program focuses on the complexities of co-occurring disorders—particularly bipolar disorder and substance abuse—using evidence-based methods that promote holistic healing and long-term recovery. Services are offered through flexible treatment tracks, including inpatient, outpatient, and partial hospitalization (PHP) programs. Key services include:
✔ Psychiatric evaluation and medication management
✔ Integrated therapy for bipolar disorder and addiction
✔ Cognitive-Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT)
✔ Holistic therapies, including mindfulness and stress-reduction techniques
✔ Family counseling and education
✔ Relapse prevention planning
✔ Peer support and group therapy
✔ Case management and aftercare coordination
The center's dual diagnosis program is designed to stabilize mood disorders while addressing the underlying causes of substance abuse. Through integrated care, individuals can regain control of their mental health and overcome the cycle of addiction.
Addressing the Complexity of Bipolar and Addiction
Bipolar disorder is often misdiagnosed or misunderstood, leading to ineffective treatment when coupled with substance abuse. The Freedom Center's experienced team recognizes that mood instability, impulsivity, and emotional distress often drive substance use in individuals with bipolar disorder. Their coordinated approach ensures both conditions are treated in tandem, reducing the risk of relapse and improving overall outcomes.
Whether a client is experiencing manic episodes, depressive episodes, or rapid cycling, The Freedom Center provides individualized support and psychiatric care to help stabilize symptoms and foster healthy coping strategies.
Get Help Today
If you or a loved one is struggling with bipolar disorder and substance abuse, The Freedom Center in Buckeystown, MD, is here to help. Through our integrated, evidence-based programs, clients can find hope, healing, and a path to recovery.
The Freedom Center – Buckeystown, MD
Address: 3521 Buckeystown Pike, Buckeystown, MD 21717
Phone: (888) 530-5025
Hours: 24/7
Website: www.thefreedomcenter.com
About The Freedom Center
The Freedom Center is a premier addiction and mental health treatment provider offering comprehensive services across Maryland. Specializing in dual diagnosis care, The Freedom Center is dedicated to helping individuals with co-occurring disorders like bipolar disorder and substance abuse reclaim their lives through evidence-based treatment, compassionate support, and personalized care.
Admissions Office
The Freedom Center Maryland Drug & Alcohol Rehab Buckeystown
+1 (888) 530-5025
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform
BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform

Yahoo

time10 minutes ago

  • Yahoo

BNP Paribas Exane Upgrades Novo Nordisk (NVO) to Neutral from Underperform

Novo Nordisk A/S (NYSE:NVO) is one of the top cheap stocks that will go to the moon according to Reddit. On August 13, BNP Paribas Exane upgraded Novo Nordisk A/S (NYSE:NVO) to Neutral from Underperform with a $54 price target. An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. The firm told investors that it sees a more balanced risk/reward now that the company's 'reality' is better reflected in the shares. Novo Nordisk A/S (NYSE:NVO) announced results for the January 1 to June 30 period on August 6, reporting an operating profit growth of 25% in Danish kroner and 29% at constant exchange rates (CER) to DKK 72.2 billion. Management also stated that sales in US Operations rose by 16% in Danish kroner (17% at CER), while sales in International Operations grew by 16% in Danish kroner (19% at CER). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in diabetes care. It develops, discovers, manufactures, and markets pharmaceutical products. Its operations are divided into two business segments: biopharmaceuticals and diabetes and obesity care. The latter segment covers GLP-1, insulin, and other protein-related products. While we acknowledge the potential of XXXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Jim Cramer on UnitedHealth: 'It Could Come Back'
Jim Cramer on UnitedHealth: 'It Could Come Back'

Yahoo

time40 minutes ago

  • Yahoo

Jim Cramer on UnitedHealth: 'It Could Come Back'

UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer shed light on. Cramer showed a slight bit of optimism toward the company as he said: 'I think UnitedHealth's going to work here… I think it's going to work. I really do. Look, I'm not a believer. I don't like the fact that they had shenanigans, but I will say this: I think that the company is run by a very good CEO. It could come back.' Ken Wolter/ UnitedHealth Group Incorporated (NYSE:UNH) provides health benefits, pharmacy care, care delivery, and health management services. In addition, the company offers data analytics and technology-driven solutions for individuals, employers, governments, and health systems. During the August 7 episode, when a caller inquired about the company stock, Cramer responded: 'I have long known, this is something I learned probably in my second decade of trading or investing: You do not buy or sell something where you have no idea what is really happening. And at UnitedHealth, there isn't anyone other than the CEO and probably 52,000 lawyers who has any idea what's going on.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos

Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)
Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)

Yahoo

time40 minutes ago

  • Yahoo

Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best stocks to invest in for beginners. Piper Sandler analyst Jessica Tassan reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on August 5, setting a price target of $280.00. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) reported that its Q2 2025 revenue underwent a $12.8 billion year-over-year growth to $111.6 billion, attributed primarily to growth within Optum and UnitedHealthcare. Earnings from operations for the quarter were $5.2 billion, while adjusted net earnings were $4.08 per share. Management reported a full year 2025 revenue outlook in the $445.5 billion to $448.0 billion range, with a full year 2025 earnings outlook of at least $14.65 per share. UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store